Healthy Inc > Blog > WHO-GMP pharma Mumbai
Posted on:

What is glucosamine chondroitin 500 400 mg used for?

In the pharmaceutical and nutraceutical industry, the combination of Glucosamine (500 mg) and Chondroitin (400 mg) is a staple “Joint Support” formulation. As a pharmacist, I classify this as a SYSADOA (Symptomatic Slow-Acting Drug in Osteoarthritis). Unlike NSAIDs, which provide immediate but temporary pain relief, this combination is designed to support the underlying health of the joint tissue over a period of 4–8 weeks.

Primary Clinical Uses

  • Osteoarthritis (OA): Primarily used to manage symptoms of mild-to-moderate osteoarthritis, particularly of the knee, hip, and spine.

  • Joint Pain and Stiffness: Reduces pain and improves physical function in individuals suffering from age-related or “wear-and-tear” joint degeneration.

  • Cartilage Preservation: Used as a prophylactic measure by athletes or individuals with heavy physical loads to protect joint integrity.

  • Recovery Support: Aids in the recovery from joint injuries or surgeries by providing the necessary building blocks for tissue repair.

Mechanism of Action: The Structural Approach

This combination works synergistically to support the Extracellular Matrix (ECM) of the cartilage:

Glucosamine (500 mg): An amino sugar that acts as a precursor for glycosaminoglycans (GAGs). It stimulates the chondrocytes (cartilage cells) to produce more collagen and proteoglycans, the “scaffolding” of the joint.

Chondroitin (400 mg): A complex carbohydrate that provides cartilage with its mechanical properties—specifically elasticity and resistance to compression. It also inhibits the enzymes (like collagenase) that break down cartilage and promotes water retention within the joint, acting as a “shock absorber.”

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, this combination is a high-volume product with specific quality requirements:

  • Source Differentiation: As a WHO-GMP firm, we differentiate between Glucosamine Sulfate and Glucosamine HCl. While Sulfate is the most researched, the HCl version is often used in higher concentrations. We also offer Vegan Glucosamine (fermented) versus traditional marine-derived (shellfish) sources to capture diverse B2B market segments.

  • Molecular Weight of Chondroitin: The efficacy of Chondroitin depends on its molecular weight for absorption. We ensure our API has low molecular weight to maximize bioavailability.

  • Stability & Shelf Life: These molecules are sensitive to high humidity. We utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions (Africa, SE Asia).

  • Regulatory & Dossiers: While often classified as a food supplement, many regions require CTD/eCTD Dossiers for therapeutic claims. Our Mumbai facility provides the technical data needed for international registration.

Glucosamine Sulphate Chondroitin Sulphate Tablets

Posted on:

What is Glimepiride pioglitazone metformin hydrochloride tablets used for?

In the pharmaceutical industry, the triple fixed-dose combination (FDC) of Glimepiride, Pioglitazone, and Metformin Hydrochloride is a high-potency “anti-diabetic cocktail.” As a pharmacist and manufacturer, I view this formulation as a comprehensive approach for patients with Type 2 Diabetes Mellitus (T2DM) who have failed to achieve glycemic control with dual therapy (usually Metformin + a Sulfonylurea).

This combination is specifically designed to address the “triumvirate” of diabetic pathology: insulin deficiency, hepatic glucose overproduction, and peripheral insulin resistance.

Primary Clinical Use

  • Refractory Type 2 Diabetes: Indicated as third-line therapy for patients who require aggressive glycemic control to reach HbA1c targets. It is highly effective but requires careful patient selection due to the complex side-effect profiles of the individual components.

Triple Mechanism of Action (The Synergy)

Glimepiride (Sulfonylurea): Functions as a secretagogue. It stimulates the pancreatic beta cells to release more insulin by closing ATP-sensitive potassium channels.

Metformin (Biguanide): Functions as an insulin sensitizer and hepatic suppressant. It reduces the amount of glucose produced by the liver and improves glucose uptake in the muscles.

Pioglitazone (Thiazolidinedione/TZD): Functions as a PPAR-gamma agonist. It works primarily in the adipose tissue, skeletal muscle, and liver to increase insulin sensitivity at the cellular level, effectively “unlocking” cells to allow glucose entry.

The Manufacturer’s Perspective: Technical & Export Challenges

Producing a triple-combination tablet like this in a WHO-GMP facility involves significant pharmaceutical engineering:

  • Bilayer or Trilayers: Because Metformin is usually present in high doses (500mg) while Glimepiride is micro-dosed (1mg or 2mg), we often use bilayer technology. One layer contains the Sustained Release (SR) Metformin, while the other contains the immediate-release Glimepiride and Pioglitazone.

  • Stability of Pioglitazone: Pioglitazone is sensitive to moisture. As a firm owner, you know that keeping the moisture content ($LOD$) of the granules low is critical to prevent degradation.

  • Content Uniformity: Achieving a homogeneous mix of 1mg Glimepiride within a large tablet is a challenge. We utilize high-shear granulation and validated mixing times to ensure every tablet meets BP/USP/IP standards.

  • Packaging for Export: Due to the sensitivity of the ingredients and the complexity of the FDC, we strictly use Alu-Alu blister packaging. This provides the maximum barrier against light and moisture, ensuring a 24 to 36-month shelf life for export to Zone IVb regions.

  • Regulatory Documentation: This is a “Value-Added Generic.” Our Mumbai facility provides comprehensive CTD/eCTD Dossiers and bioequivalence data to support our B2B partners in international markets.

Glimepiride with pioglitazone metformin hydrochloride sr Tablets

Posted on:

What is the use of niacinamide and folic acid tablet?

In the pharmaceutical industry, the combination of Niacinamide (Vitamin B3) and Folic Acid (Vitamin B9) is typically formulated as a potent hematinic and neurotrophic supplement. As a pharmacist, I view this combination as a targeted therapy for correcting specific nutritional deficiencies that impact both blood health and cellular energy metabolism.

Primary Clinical Uses

  • Nutritional Deficiency Anemia: Used to treat and prevent megaloblastic anemia, where Folic Acid is required for healthy red blood cell maturation.

  • Support for Pregnancy: Frequently prescribed to ensure healthy fetal neural tube development (Folic Acid) while supporting maternal skin and energy metabolism (Niacinamide).

  • Management of Pellagra: Niacinamide is the primary treatment for Pellagra (B3 deficiency), characterized by dermatitis, diarrhea, and dementia.

  • Neuropathy & Nerve Health: Niacinamide supports the repair of nerve cells, making this combination useful as an adjunct in diabetic neuropathy or general nerve weakness.

  • Skin Health: Often used in dermatology to reduce inflammation in conditions like acne or bullous pemphigoid, as Niacinamide improves the skin’s barrier function.

Mechanism of Action

These two B-vitamins work through distinct but complementary biochemical pathways:

Folic Acid (Vitamin B9): It is a precursor to tetrahydrofolate, which is essential for DNA synthesis and amino acid metabolism. Without it, cells cannot divide properly, which is most evident in rapidly dividing tissues like bone marrow (red blood cell production).

Niacinamide (Vitamin B3): It is a precursor to the coenzymes NAD and NADP, which are vital for ATP (energy) production in the mitochondria. It also inhibits the release of inflammatory cytokines, providing a protective effect on tissues.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, this combination is a stable, high-demand “lifestyle and wellness” product:

  • API Compatibility: Both Niacinamide and Folic Acid are generally compatible in a solid oral dosage form. As a WHO-GMP manufacturer, we ensure the formulation remains stable by controlling the pH and utilizing moisture-resistant excipients.

  • Dose Accuracy: Folic Acid is often required in micro-doses (e.g., 5 mg or less). We utilize validated geometric dilution to ensure content uniformity across every tablet in a batch.

  • Stability for Export: B-Vitamins are sensitive to light and high humidity. We utilize Alu-Alu or Amber-colored PVC blister packaging to maintain a 24–36 month shelf life for export to Zone IVb regions (Africa and Southeast Asia).

  • B2B & Multi-Vendor Synergy: This is a staple product for “Private Label” opportunities on digital marketplaces. Our Mumbai facility provides the CTD/eCTD Dossiers and stability data required for international registration

Ferrous fumarate with folic acid Tablet

Posted on:

What is iron ferrous fumarate 60mg and folic acid 400mcg tablets?

In the pharmaceutical industry, Ferrous Fumarate (60 mg elemental iron) and Folic Acid (400 mcg) is a foundational haematinic combination. As a pharmacist, you recognize this as the “Gold Standard” for preventing and treating Iron Deficiency Anemia (IDA), particularly in maternal health and public health intervention programs.

Primary Clinical Uses

  • Prenatal Care: Routine supplementation during pregnancy to prevent maternal anemia and support fetal neural tube development.

  • Prevention of Anemia: Used in populations at high risk of iron deficiency, such as adolescent girls and women of childbearing age.

  • Treatment of IDA: Management of established iron deficiency where oral supplementation is appropriate.

  • Megaloblastic Anemia Prevention: The Folic Acid component specifically prevents anemias characterized by large, immature red blood cells.

Mechanism of Action

This combination addresses the two most common nutritional causes of anemia:

Ferrous Fumarate (Iron): Iron is a core component of Hemoglobin. Ferrous Fumarate is an anhydrous salt that provides a high percentage of elemental iron (approx. 33%). Once absorbed, it is incorporated into heme, allowing red blood cells to transport oxygen from the lungs to the rest of the body.

Folic Acid (Vitamin B9): Folic Acid is a precursor to tetrahydrofolate, which is essential for DNA synthesis and red blood cell maturation. It works synergistically with Iron to ensure that the new red blood cells being produced are healthy and functional.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, this is a high-volume “Essential Medicine” with specific technical nuances:

  • Elemental Iron Calculation: As a firm owner, you know that 60 mg of Elemental Iron requires approximately 182 mg of Ferrous Fumarate API. Clear labeling of both the salt weight and the elemental weight is crucial for international B2B transparency.

  • Stability & Oxidation: Iron salts are prone to oxidation. As a WHO-GMP manufacturer, we utilize film-coating technology to protect the API from moisture and to mask the metallic taste, which significantly improves patient compliance.

  • Packaging for Global Tenders: This product is a staple for UNICEF, WHO, and national health ministries. We prioritize Alu-Alu or high-density PVC/PVDC blister packaging to ensure a 36-month shelf life in Zone IVb climates (Africa and SE Asia).

  • Dossier Support: Our Mumbai-based facility provides complete CTD/eCTD Dossiers to support rapid registration in international markets, focusing on dissolution profiles and stability data.

Ferrous Folic Tablets

 

Posted on:

How do etophylline and theophylline work?

In the pharmaceutical industry, the combination of Etophylline and Theophylline is a classic xanthine-derivative bronchodilator therapy. As a pharmacist, I characterize this duo as a synergistic approach to managing obstructive airway diseases.

While they are both methylxanthines, they serve slightly different roles in a formulation: Theophylline is the primary active bronchodilator, while Etophylline (a derivative of theophylline) is often added because it is more water-soluble, which helps improve the overall absorption and “speed” of the medication’s effect.

Mechanism of Action: The Triple-Action Pathway

These compounds work through three primary biochemical mechanisms to open the airways:

1. Phosphodiesterase (PDE) Inhibition

The primary action is the non-selective inhibition of Phosphodiesterase enzymes (mainly PDE3 and PDE4).

  • Normally, PDE breaks down cyclic AMP (cAMP) in the smooth muscles of the lungs.

  • By blocking PDE, Etophylline and Theophylline cause cAMP levels to rise.

  • High cAMP levels lead to significant smooth muscle relaxation, resulting in bronchodilation.

2. Adenosine Receptor Antagonism

Adenosine is a natural substance that can cause bronchoconstriction (narrowing of the airways) in asthmatic patients.

  • These drugs act as competitive antagonists at adenosine $A_1$ and $A_2$ receptors.

  • By blocking these receptors, they prevent adenosine-mediated airway constriction and histamine release from mast cells.

3. Histone Deacetylase (HDAC) Activation

At lower clinical doses, theophylline has been shown to activate HDAC2.

  • This is a critical “anti-inflammatory” mechanism.

  • It helps switch off activated inflammatory genes, which can actually help restore a patient’s sensitivity to corticosteroids (often used in COPD and severe asthma).

Primary Clinical Uses

  • Bronchial Asthma: For both maintenance therapy and relief of acute bronchospasm.

  • Chronic Obstructive Pulmonary Disease (COPD): Including chronic bronchitis and emphysema.

  • Apnea of Prematurity: Occasionally used in neonatal care to stimulate the respiratory center.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing standpoint, particularly for an export-focused firm like yours in Mumbai, this combination (often seen in the brand Deriphyllin) presents specific technical considerations:

  • Solubility Optimization: The inclusion of Etophylline is a strategic manufacturing choice to overcome the poor water solubility of pure Theophylline base. This ensures better bioavailability in both tablet and injectable forms.

  • Sustained Release (SR) Technology: Because these drugs have a narrow therapeutic index (the gap between a healing dose and a toxic dose), we often manufacture them as Sustained Release tablets. This prevents “spikes” in blood concentration and reduces side effects like palpitations or tremors.

  • Stability for Zone IVb: Xanthines are generally stable, but we utilize Alu-Alu blister packaging to protect the integrity of the SR matrix from the high humidity found in African and SE Asian export markets.

  • Regulatory Documentation: Our Mumbai facility provides full CTD/eCTD Dossiers to support B2B partners, emphasizing the bioequivalence of the Etophylline/Theophylline ratio.

Etofylline Theophylline Tablets

Posted on:

What is diltiazem 60 mg used for?

In the pharmaceutical industry, Diltiazem Hydrochloride 60 mg is a benzothiazepine-class Calcium Channel Blocker (CCB). As a pharmacist, I classify this as a “Non-Dihydropyridine” CCB, which is technically significant because unlike Amlodipine (which mainly affects blood vessels), Diltiazem has a balanced effect on both the coronary arteries and the heart’s conduction system.

Primary Clinical Uses

  • Angina Pectoris: Used for the chronic management of stable angina (chest pain) and vasospastic (Prinzmetal’s) angina by increasing oxygen delivery to the heart muscle.

  • Hypertension: Used as a standalone or adjunctive therapy to lower blood pressure, particularly in patients who cannot tolerate beta-blockers.

  • Atrial Fibrillation and Flutter: Utilized to control the ventricular heart rate in patients with supraventricular tachyarrhythmias.

  • Raynaud’s Phenomenon: Occasionally used off-label to improve peripheral circulation and reduce the frequency of vasospasms in the fingers and toes.Mechanism of Action

Diltiazem works by inhibiting the influx of calcium ions during membrane depolarization of cardiac and vascular smooth muscle.

Coronary Vasodilation: It relaxes the smooth muscles of the coronary arteries, increasing blood flow and oxygen to the myocardium.

Peripheral Vasodilation: It reduces peripheral vascular resistance, which lowers systemic blood pressure.

Negative Chronotropic/Dromotropic Effects: It slows the conduction through the Atrioventricular (AV) node and decreases the heart rate, reducing the workload on the heart.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Diltiazem 60 mg is a precision cardiovascular product:

  • Immediate vs. Extended Release: The 60 mg tablet is typically the Immediate Release (IR) version, often dosed three to four times daily. As a WHO-GMP manufacturer, we ensure the dissolution profile is tightly controlled to avoid “dose dumping.”

  • API Stability: Diltiazem is sensitive to moisture and light. We utilize Alu-Alu blister packaging to ensure a stable 36-month shelf life, which is a critical requirement for export to Zone IVb regions (hot and humid climates).

  • Bioequivalence: We maintain rigorous standards to ensure our generic version matches the innovator (Cardizem) in plasma concentration levels.

  • Global Regulatory Support: Our Mumbai facility provides full CTD/eCTD Dossiers and stability data to facilitate rapid registration for international B2B partners and government tenders.

Diltiazem Tablets

Posted on:

What is digoxin 62.5 mcg used for?

In the pharmaceutical industry, Digoxin 62.5 mcg is a specialized, low-dose cardiac glycoside derived from the digitalis (foxglove) plant. As a pharmacist, I view this specific strength as a critical “maintenance or titration dose,” primarily used for elderly patients or those with impaired renal function where the risk of toxicity is high.

Primary Clinical Uses

  • Atrial Fibrillation (AFib): Used to control the ventricular rate in patients with chronic atrial fibrillation or atrial flutter. It slows down the electrical conduction through the AV node.

  • Heart Failure (HF): Indicated for the management of mild-to-moderate heart failure in adults. It is typically used as an adjunct to other therapies (like ACE inhibitors and beta-blockers) to improve heart contraction and exercise tolerance.

  • Pediatric Cardiology: The 62.5 mcg strength is frequently used in pediatric dosing for infants and children with congenital heart defects or heart failure.

Mechanism of Action: The “Inotropic & Chronotropic” Effect

Digoxin works through a very specific biochemical pathway in the cardiac myocytes:

Inhibition of the Na+/K+-ATPase Pump: It binds to and inhibits this pump on the cell membrane. This leads to an increase in intracellular sodium ($Na^+$).

Positive Inotropic Effect: The rise in sodium leads to an increase in intracellular calcium ($Ca^{2+}$) via the sodium-calcium exchanger. More calcium means the heart muscle fibers can contract more forcefully (strengthening the heartbeat).

Negative Chronotropic Effect: Digoxin increases vagal (parasympathetic) tone. This slows the heart rate and slows conduction through the Atrioventricular (AV) node, which is crucial for managing rapid heart rhythms like AFib.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Digoxin is a “Narrow Therapeutic Index” (NTI) drug, meaning the difference between a therapeutic dose and a toxic dose is very small.

  • Micro-Dose Precision: Since 62.5 mcg is an extremely minute amount of API, as a WHO-GMP manufacturer, we utilize validated trituration and geometric dilution to ensure absolute content uniformity. A 10% deviation in this product can have life-threatening consequences for the patient.

  • API Sourcing & Stability: Digoxin API must be extremely pure. We monitor for related substances and ensure the product is protected from light and moisture using Alu-Alu blister packaging, ensuring a 36-month shelf life for export to Zone IVb regions.

  • Niche Market Supply: While high-volume items like Paracetamol dominate, Digoxin 62.5 mcg is a vital niche product for specialized B2B distributors and cardiovascular hospitals.

  • Regulatory Compliance: Our Mumbai facility provides full CTD/eCTD Dossiers and bioequivalence studies (which are mandatory for NTI drugs in many countries) to support international registration.

Digoxin Tablets

 

Posted on:

What is dicyclomine HCL 20 mg used for?

In the pharmaceutical industry, Dicyclomine Hydrochloride 20 mg is a synthetic antispasmodic and anticholinergic agent. As a pharmacist, I characterize this as a “smooth muscle relaxant” that specifically targets the gastrointestinal tract to alleviate cramp-like pain.

Primary Clinical Uses

  • Irritable Bowel Syndrome (IBS): Used to treat the functional symptoms of IBS, such as abdominal pain, bloating, and irregular bowel movements.

  • Gastrointestinal Spasms: Relieves acute spasms of the GI tract caused by various functional disorders.

  • Colic: In specific cases (and often in lower doses or different formulations for pediatrics), it is used to manage infant colic, though its use in infants is highly restricted due to safety profiles.

  • Adjunctive Therapy: Often used alongside other treatments for peptic ulcers or enterocolitis to reduce the pain associated with hypermotility.

Mechanism of Action

Dicyclomine works through a dual-action pathway to relax the gut:

Antimuscarinic Action: It competitively blocks acetylcholine at the muscarinic receptors ($M_3$ subtype) located on the smooth muscle of the gastrointestinal tract. By blocking these signals, it stops the involuntary muscle contractions (spasms).

Direct Spasmolytic Effect: It also has a direct effect on the smooth muscle itself, independent of the nervous system, which helps ensure the muscle remains in a relaxed state.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Dicyclomine 20 mg is a high-demand “GIT specialty” product:

  • Fixed-Dose Combinations (FDCs): As a WHO-GMP manufacturer, we often formulate Dicyclomine with Paracetamol or Mefenamic Acid (e.g., for menstrual or spasmodic pain). The technical challenge is maintaining the stability of Dicyclomine in these multi-API matrices.

  • Bioavailability & Assay: We adhere to strict BP/USP/IP monographs, ensuring that the 20 mg dose is released uniformly. We utilize validated dissolution testing to guarantee that the drug acts quickly once ingested.

  • Packaging for Export: Dicyclomine is sensitive to environmental degradation. We utilize PVC/PVDC or Alu-Alu blister packaging to ensure a stable 36-month shelf life, particularly for export to Zone IVb regions like Africa and Southeast Asia.

  • Regulatory Compliance: Our Mumbai-based facility provides comprehensive CTD/eCTD Dossiers to support international B2B registration and hospital tenders.

Dicyclomine Tablets

Posted on:

What is diclofenac sodium 50mg and Paracetamol used for?

In the pharmaceutical industry, the combination of Diclofenac Sodium (50 mg) and Paracetamol (325 mg or 500 mg) is one of the most widely prescribed Fixed-Dose Combinations (FDCs) for analgesia. As a pharmacist, I view this as a “dual-pathway” strategy: it combines the potent peripheral anti-inflammatory action of Diclofenac with the central analgesic and antipyretic effects of Paracetamol.

Primary Clinical Uses

  • Acute Musculoskeletal Pain: Highly effective for backaches, sprains, strains, and sports injuries where both pain and inflammation are present.

  • Post-Operative Recovery: Used to manage moderate-to-severe pain following surgical or dental procedures.

  • Arthritic Flare-ups: Provides symptomatic relief for acute episodes of Rheumatoid Arthritis, Osteoarthritis, and Ankylosing Spondylitis.

  • Gynaecological Pain: Frequently prescribed for severe primary dysmenorrhea (period pain).

  • Dental Pain: Effective for toothaches and post-extraction inflammation.

Mechanism of Action: The “Synergistic Punch”

This combination targets pain from two different angles:

Diclofenac Sodium (NSAID): It primarily inhibits the COX-2 enzyme, blocking the production of prostaglandins at the site of injury (periphery). This reduces the actual swelling and redness of the tissue.

Paracetamol (Analgesic/Antipyretic): While its exact mechanism is still debated, it is believed to act primarily on the Central Nervous System (CNS). It increases the overall pain threshold and reduces fever by acting on the heat-regulating center of the hypothalamus.

By combining them, you achieve a “sparing effect”—using a moderate dose of each to get a stronger result than a high dose of either alone, which often leads to a better safety profile for the patient.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, this FDC is a high-volume “bread and butter” product for export:

  • Bilayer vs. Monolithic Tablet: As a WHO-GMP manufacturer, we often look at the stability of the two APIs. While they are generally compatible, we ensure strict moisture control during granulation to prevent the degradation of Paracetamol.

  • Gastric Protection: Diclofenac is known for GI irritation. We often use enteric-coated Diclofenac pellets or specialized film-coating for the tablet to protect the stomach lining, enhancing patient compliance.

  • Global Demand & Tenders: This combination is a staple for B2B distributors and government health tenders in Africa, Southeast Asia, and the CIS. It is a highly competitive but high-turnover product.

  • Packaging for Stability: We prioritize Alu-Alu or high-grade PVC/PVDC blister packaging to ensure a stable 36-month shelf life in Zone IVb (hot and humid) climates.

  • Regulatory Compliance: Our Mumbai facility provides full CTD/eCTD Dossiers and comparative dissolution data to assist our international partners with registration.

Paracetamol Diclofenac sodium tablets

 

Posted on:

What is diclofenac sodium 25 mg used for?

In the pharmaceutical industry, Diclofenac Sodium 25 mg is a potent non-steroidal anti-inflammatory drug (NSAID) of the phenylacetic acid derivative class. As a pharmacist, I view the 25 mg strength as a versatile “titration dose,” often used for acute pain management or as a starting dose to minimize gastrointestinal (GI) side effects.

Primary Clinical Uses

  • Acute Pain Management: Effective for the short-term relief of mild to moderate pain, such as toothaches, primary dysmenorrhea (period pain), and post-operative pain.

  • Inflammatory Conditions: Used to treat symptoms of Rheumatoid Arthritis (RA), Osteoarthritis (OA), and Ankylosing Spondylitis.

  • Musculoskeletal Disorders: Relieves pain and inflammation associated with sprains, strains, backache, and tendonitis.

  • Migraine Attacks: In specific fast-acting formulations (like potassium salts or specific sodium dispersibles), it is used to treat acute migraine episodes.

    Mechanism of Action

Diclofenac Sodium works by inhibiting the enzyme Cyclooxygenase (COX). Specifically, it inhibits both COX-1 and COX-2, though it shows a slight preference for COX-2.

By blocking these enzymes, Diclofenac prevents the synthesis of prostaglandins—the chemical messengers responsible for signaling pain, inducing fever, and causing inflammation. Unlike the potassium salt version (which is faster-acting), the sodium salt is typically formulated for a slightly more sustained release to provide longer-lasting relief.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Diclofenac Sodium is a high-volume “essential” product:

  • Enteric Coating (Critical): Diclofenac is notorious for causing gastric irritation. As a WHO-GMP manufacturer, we almost always apply a high-quality enteric coating to these tablets. This ensures the drug bypasses the acidic environment of the stomach and dissolves in the small intestine, significantly improving patient tolerance.

  • Stability & Shelf Life: Diclofenac is stable, but sensitive to moisture. We utilize Alu-Alu blister packaging to ensure a 36-month shelf life, which is a key selling point for export to Zone IVb regions like Africa, Southeast Asia, and the Middle East.

  • Regulatory Documentation: We provide full CTD/eCTD Dossiers and comparative dissolution studies against the innovator (Voltaren) to support our B2B partners in rapid international registration.

  • Market Positioning: The 25 mg dose is frequently used in pediatric or geriatric populations where lower dosing is required to manage the safety profile.

Paracetamol Diclofenac sodium tablets

Add to cart